Round Table Session: What are the advantages of POT balloon over conventional NCB
Release time:
2022-12-07
12 December @ 8:00 – 10:00 (CET time), 15:00-17:00 (Beijing time)
12 December @ 8:00 – 10:00 (CET time), 15:00-17:00 (Beijing time)
Join us for this broadcasted round table session to hear about the insight from well-known professors about POT technique and BrosMed POT balloon dilatation catheter (which is dedicated for coronary bifurcation stenting). Also, we will share the extensive research and clinical data of POT study to show the advantages of POT balloon over conventional Non-compliant balloon.
We’re excited to have Professor Shaoliang Chen (MD, PhD, FSCAI, FACC, FESC, JSCAI Editorial Board, China) as session chairman; Professor Antonio Colombo (MD, FACC, MSCAI, Deemed a “Legend in Cardiovascular Disease”, Italy), Prof. Dobrin Vassilev (MD, PhD, Bulgaria), Prof. Lefeng Wang( MD, PhD, China) and Dr. Choo Gim Hooi (MD, Malaysia) as our Panel Discussion, also with 3 Honored Speakers: Dr. Gregor Leibundgut (Switzerland), Dr. Stefano Galli (Italy) and Dr. Wangang Guo (China).
Please Scan the QR code on the poster or Click the Link to register and join with us and watch the live broadcast.
Stay tuned and don’t miss out on this exciting event!
Previous Article
Next Article
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27